KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Short-Term Debt issuances (2016)

Novavax (NVAX) has 7 years of Short-Term Debt issuances data on record, last reported at -$45000.0 in Q4 2016.

  • For Q4 2016, Short-Term Debt issuances rose 68.31% year-over-year to -$45000.0; the TTM value through Sep 2017 reached -$45000.0, up 90.85%, while the annual FY2016 figure was -$395000.0, 34.17% up from the prior year.
  • Short-Term Debt issuances reached -$45000.0 in Q4 2016 per NVAX's latest filing, up from -$104000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at -$7000.0 in Q2 2012 and bottomed at -$170000.0 in Q2 2014.
  • Average Short-Term Debt issuances over 5 years is -$115736.8, with a median of -$143000.0 recorded in 2015.
  • Peak YoY movement for Short-Term Debt issuances: crashed 1285.71% in 2013, then soared 68.31% in 2016.
  • A 5-year view of Short-Term Debt issuances shows it stood at -$40000.0 in 2012, then tumbled by 320.0% to -$168000.0 in 2013, then rose by 1.19% to -$166000.0 in 2014, then increased by 14.46% to -$142000.0 in 2015, then skyrocketed by 68.31% to -$45000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were -$45000.0 in Q4 2016, -$104000.0 in Q3 2016, and -$103000.0 in Q2 2016.